Efficacy and safety of cord blood-derived dendritic cells plus cytokine-induced killer cells combined with chemotherapy in the treatment of patients with advanced gastric cancer: a randomized Phase II study

BACKGROUND: Cellular immunotherapy has been widely used in the treatment of solid tumors. However, the clinical application of cord blood-derived dendritic cells and cytokine-induced killer cells (CB-DC-CIK) for the treatment of gastric cancer has not been frequently reported. In this study, the eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Mu, Ying, Wang, Wei-hua, Xie, Jia-ping, Zhang, Ying-xin, Yang, Ya-pei, Zhou, Chang-hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4966574/
https://www.ncbi.nlm.nih.gov/pubmed/27524915
http://dx.doi.org/10.2147/OTT.S107745

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4966574/
https://www.ncbi.nlm.nih.gov/pubmed/27524915
http://dx.doi.org/10.2147/OTT.S107745

Ejemplares similares